Second Affiliated Hospital Of Xi'an Jiaotong University

This study tests a new two-drug approach for liver cancer patients whose tumors show 'tumor budding,' a sign of high recurrence risk. After surgery, participants receive a collagen-degrading drug plus a targeted therapy to help drugs reach cancer cells and kill them. The goal is …